secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001493152-24-021353
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma amends bylaws to streamline director count setting
-----------------------------------------------------------------

- Board of Directors approved amendment to Section 3.02 of Bylaws on May 23, 2024, effective immediately.
- Previous language required a majority of total directors (including vacancies) to set board size; now any board resolution suffices.
- Authorized board size remains unchanged at minimum 3 and maximum 9 directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315224021353/0001493152-24-021353-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315224021353/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-021353

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer